Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi

suck pdf from helios


suck pdf from google scholar
unlimited free pdf from europmc32277387    free
PDF from PMC    free
html from PMC    free
PDF vom PMID32277387  :  Publisher

suck abstract from ncbi

Nephropedia Template TP Text

Twit Text FOAVip

Twit Text #

English Wikipedia

  • Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation #MMPMID32277387
  • Liu H; He X; Wang Y; Zhou S; Zhang D; Zhu J; He Q; Zhu Z; Li G; Sun L; Wang J; Cheng G; Liu Z; Lau G
  • Hepatol Int 2020[Jul]; 14 (4): 432-436 PMID32277387show ga
  • Annually, around 850 liver transplantation is performed in Beijing, China. Recently, the new coronavirus pneumonia (COVID-19) caused by 2019 novel coronavirus (2019-nCoV) has affected nearly 200 countries worldwide. 2019-nCov can cause severe lung disease, multiple-organ damage, and significant mortalities. Liver transplant recipients, because of long-term oral immunosuppressant effects, may be more susceptible to 2019-nCoV infection and have a worse prognosis than the general population. It is urgent to set up guidelines for the prevention, diagnosis, and treatment of COVID-19 in liver transplant recipients. In this article, we reviewed the clinical aspects of 2019-nCoV infection, characteristics of liver transplant recipients, immunosuppressant usage, and potential drug interactions to provide recommendations to clinical staff managing liver transplant recipients during the COVID-19 epidemic.
  • |*Betacoronavirus[MESH]
  • |*Liver Transplantation[MESH]
  • |COVID-19[MESH]
  • |China[MESH]
  • |Coronavirus Infections/*complications/*diagnosis/therapy[MESH]
  • |Humans[MESH]
  • |Liver Diseases/*diagnosis/etiology/*therapy[MESH]
  • |Pandemics[MESH]
  • |Patient Selection[MESH]
  • |Pneumonia, Viral/*complications/*diagnosis/therapy[MESH]
  • |Practice Guidelines as Topic[MESH]
  • |SARS-CoV-2[MESH]
  • |Societies, Medical[MESH]
  • |Symptom Assessment[MESH]

  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    432 4.14 2020